Cas:93964-77-3 L-Arginine L-malate manufacturer & supplier

Chemical Name:L-Arginine L-malate

CAS.NO:93964-77-3

Synonyms:Rocmalate;1,2,3,4-Tetrahydro-3-isoquinolinecarboxylic acid hydrochloride;(S)-2-amino-5-guanidinopentanoic acid compound with (S)-2-hydroxysuccinic acid;UNII-4ZWH2B7Q0Q;Arginine malate;L-Arginine L-malate;1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid,hydrochloride;L-Arginine malate;L-Arginine,hydroxybutanedioate;(2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid,(2S)-2-hydroxybutanedioic acid;L-Arginine – 2-hydroxysuccinic acid (1:1);L-Arginine, compd. with 2-hydroxybutanedioic acid (1:1)

Molecular Formula:C₁₀H₂₀N₄O₇

Molecular Weight:308.288

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:409.1ºC at 760mmHg

Density:N/A

Index of Refraction:

PSA:52.49000

Exact Mass:308.133209

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Rocmalate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,L-Arginine, compd. with 2-hydroxybutanedioic acid (1:1) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,L-Arginine malate Use and application,(2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid,(2S)-2-hydroxybutanedioic acid technical grade,usp/ep/jp grade.

Related News: AXON is planning a follow-up trial that will include a better-defined group of Alzheimer’s patients suffering from both amyloid plaques and tau tangles, Novak said. L-Arginine L-malate manufacturer Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance. L-Arginine L-malate supplier Active pharmaceutical ingredients directly impact disease. L-Arginine L-malate vendor Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance. L-Arginine L-malate factory Financial toxicity (FT) is more prevalent among individuals with atherosclerotic cardiovascular disease (ASCVD) than individuals with cancer, according to a study published in the June 1 issue of JACC: CardioOncology.